What are the requirements for presenting sequences in patent applications?
For patent applications filed on or after July 1, 2022, that disclose nucleic acid and/or amino acid sequences falling within the definition in 37 CFR 1.831(b), there are specific requirements for presenting these sequences. According to MPEP 2412.06:
“37 CFR 1.831(a) requires conformance to the requirements of 37 CFR 1.832 through 37 CFR 1.834 with regard to the manner in which the disclosed nucleotide and/or amino acid sequences are presented and described.”
This requirement ensures consistency in sequence representation across patent applications.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2412.06 - The Requirement For Exclusive Conformance; Sequences Presented In Drawing Figures,
Patent Law,
Patent Procedure